share_log

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Murthy Mala

Teladoc Health | 4: Statement of changes in beneficial ownership of securities

Teladoc Health | 4:持股變動聲明
SEC announcement ·  04/09 04:10
牛牛AI助理已提取核心訊息
Mala Murthy, the Acting CEO and CFO of Teladoc Health, Inc. (TDOC), was reported to have engaged in a transaction involving the company's stock on April 5, 2024. The specific details of the transaction, including the number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Murthy after the action.
Mala Murthy, the Acting CEO and CFO of Teladoc Health, Inc. (TDOC), was reported to have engaged in a transaction involving the company's stock on April 5, 2024. The specific details of the transaction, including the number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Murthy after the action.
據報道,Teladoc Health, Inc.(TDOC)代理首席執行官兼首席財務官馬拉·默西於2024年4月5日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。該報告也沒有提供有關穆爾西在行動後持有的股票數量的信息。
據報道,Teladoc Health, Inc.(TDOC)代理首席執行官兼首席財務官馬拉·默西於2024年4月5日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。該報告也沒有提供有關穆爾西在行動後持有的股票數量的信息。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。